Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune microenvironment, and immunogenicity of malignant melanoma. Historically, the prognosis ...

Innovative urinary miRNA profiling shows potential for early pancreatic cancer detection, with high accuracy and sensitivity, ...

Native species are fighting for survival from predation by rats, stoats and possums ... The programme is a critical part of ...

Reducing the risk of metastatic relapse in patients with resectable soft tissue sarcomas is crucial for improving outcomes, because metastasis is the primary cause of mortality in this population.

Researchers developed ultrasensitive nanoscale sensors for isoprene detection in breath, offering a non-invasive method for ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years.

The N-AVD regimen showed improved progression-free survival and lower toxicity than BV-AVD in advanced Hodgkin lymphoma, ...

INAVO120 clinical trial evaluated 325 patients, who were randomly assigned with Inavolisib or placebo plus palbociclib and fulvestrant. The primary endpoint was progression free survival (PFS), and ...

Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) as a monotherapy for the treatment ...

Oncology trials often celebrate treatments improving progression-free survival, yet toxicity-related censoring can bias ...

Global Breast Cancer Screening Tests Market was valued at approximately USD 2.93 billion in 2023 and is projected to grow with a healthy CAGR of 54.3% over the forecast period 2024-2032. Read the ...

The 2-year progression free survival was improved with the addition of toripalimab (92·0% [95% CI 86·7–97·3]) compared with placebo (74·0% [61·8–86·2]; stratified hazard ratio 0·40 [95% CI 0·18–0·89]; ...